Juno Biomedical, Inc. joins Singularity University’s Second Accelerator

Regenerative Medicine Startup Working to Solve One of Humanity’s Grand Challenges Mountain View, Calif., May 5, 2016 — Juno Biomedical Inc., a medtech startup developing a revolutionary technology to repair damaged brain tissue in stroke victims, has been selected by Singularity University to participate in their SU Labs Startup Accelerator program. Acceptance into the program[…]

Singularity University Selects Juno Biomedical

We are excited to announce that Juno Biomedical was selected to participate in Singularity University’s Start-up Accelerator program! This is an incredible opportunity to accelerate the availability of our technology to people around the world who suffer from neurological damage caused by stroke. Singularity University’s Accelerator Program is designed to assist companies who are working[…]

CEO Trisha Pfluger to Participate in Innovation Panel

The Sacramento Chapter of Women in Technology International (WITI) has invited Trisha Pfluger, CEO, to participate as a panelist in a discussion of trending innovations that will change our world. Juno Biomedical’s technology is poised to become a significant  feature of future medicine. The scientific principles underlying our technology are uniquely novel and unexplored as a[…]

See Juno in the Sacramento Bee

CEO Trisha Pfluger was recently interviewed for an article in the Sacramento Bee. The article comments on UC Davis’ support of start up companies like Juno Biomedical with technologies that were developed at UC Davis. Juno Biomedical works closely with the UC Davis Office of Research, and is affiliated with the UC Davis Institute for[…]